{
  "node_id": "us-fda-21-cfr-211-cgmp-finished-pharmaceuticals",
  "title": "Current Good Manufacturing Practice for Finished Pharmaceuticals",
  "domain": "Pharmaceuticals & Life Sciences",
  "version": "1.0.0",
  "last_updated": "2026-04-21",
  "bluf": "This regulation establishes the minimum requirements for methods, facilities, and controls used in the manufacturing, processing, packing, or holding of finished pharmaceuticals to…",
  "paywall": {
    "status": "LOCKED",
    "unlock_cost_usd": "0.01",
    "skyfire_id": "41779894-ece2-4163-9761-b3b1b76e19b0"
  },
  "crosswalks": {
    "_available_keys": [
      "nist_framework",
      "iso_standard",
      "industry_mapping",
      "ai_overlay_2026"
    ],
    "_note": "Full crosswalk values included in vault response"
  },
  "dependencies": [
    "fda-21-cfr-210-211-current-good-manufacturing-practice",
    "ich-q10-pharmaceutical-quality-system-2008",
    "eu-gmp-annex-1-sterile-manufacture-2022"
  ],
  "primary_citations_count": 7,
  "workflow_steps_count": 10,
  "schema_fields_count": 11,
  "citation_preview": [
    "21 CFR § 211.1 - Scope",
    "21 CFR § 211.22 - Responsibilities of quality control unit"
  ]
}